Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Hydration & Female Life Stages

Female life stages including premenopausal, perimenopausal, postmenopausal, are characterized by changing concentrations and patterns of hormones. The premenopause stage represents the reproductive years with normal menstrual cycles lasting between 21-35 days. The perimenopause stage is the beginning of the menopause transition and can last up to 10 years. During this transition, menstrual cycles become longer and irregular in length (7 days or longer). After 12 consecutive months with no period, the transition is complete into the postmenopause stage. Hormones that change across the lifespan are known to influence systems that regulate thirst, fluid balance, and sodium balance. Yet, fluid balance across life stages remains poorly understood, with no direct comparisons across all three life stages. The purpose of this study is to evaluate the effect of female life stage on rehydration with water and electrolyte solution after overnight fast and fluid restriction

Participants needed: 72
Trial details
Age: 18-60Biological sex: FemaleType: InterventionalSponsor: PepsiCo Global R&DUpdated: Sep 21, 2026Locations: 2
Eligibility criteria

• Sex assigned female at birth. [+27]

• Currently pregnant or breastfeeding [+8]

Status: Recruiting

Wearable Photoplethysmography for Non-invasive Hydration Assessment

Hydration status during exercise is often determined by measuring body mass change, fluid intake and urine output. However, obtaining these measurements can be an invasive, time-consuming process. Hydration status may be detectable by analyzing blood flow patterns of the superficial (just under the skin) blood vessels. Wearable devices are now abundant among the general population, and despite attempts from several groups, a hydration status metric based on noninvasive wearable device metrics has not been developed. With wearables, a light source connected to an optical sensor transmits and reflects light through the body. The light sensor detects absorption of the light based on wavelength measurements of the detected light. Absorption of specific wavelengths of light energy is dependent upon the amount of oxygenated blood in the vessels. When the vessels expand and relax, the amount of blood volume in the observed tissue increases and decreases potentially causing a shift in the photoplethysmography (PPG) wave detected by the wearable. The shift in the shape of the PPG wave may be detected in a way that indicates the relative change in tissue hydration levels. However, to our knowledge, no wrist worn device that utilizes PPG has been successfully able to predict hydration status. Therefore, this study aims to utilize photoplethysmography (PPG) technology in a wearable device to accomplish this approach to hydration monitoring.

Participants needed: 30
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: PepsiCo Global R&DUpdated: Sep 21, 2026Locations: 2
Eligibility criteria

Study subject is 18-45 years of age, inclusive [+12]

Subject has participated or currently enrolled in a clinical trial within the pa... [+4]

Status: Recruiting

Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes

This remote study will evaluate the feasibility of using the Gatorade Sports Science Institute (GSSI) Labs App for remotely collecting hydration related outcomes.

Participants needed: 200
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: PepsiCo Global R&DUpdated: Jun 5, 2025Locations: 1
Eligibility criteria

18-65 years of age, inclusive [+7]

Subject is currently enrolled in a clinical trial or has participated in a clini... [+1]

Status: Recruiting

The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery

To investigate the effect of Vicia faba protein concentrate, a protein derived from Fava bean extract, on delayed onset muscle soreness (DOMS). Participants receive either 2.4g/day of PeptiStrong® supplement capsules or placebo capsules for 14 days until a strenuous exercise session. For the last 3 days, 2/3 of them stay on the same treatment and 1/3 of them switch from placebo to PeptiStrong®.

Participants needed: 76
Trial details
Age: 18-45Biological sex: AllType: InterventionalSponsor: PepsiCo Global R&DUpdated: Feb 20, 2025Locations: 1
Eligibility criteria

Males and females 18 - 45 years of age. [+11]

Individuals that are glucose-6-phosphate-dehydrogenase deficient. The test produ... [+16]